Menu
Search
|

Menu

Close
X

Piramal Enterprises Ltd PIRA.BO (Bombay Stock Exchange)

2,510.00 INR
-10.80 (-0.43%)
As of Jul 20
chart
Previous Close 2,520.80
Open 2,501.00
Volume 2,833
3m Avg Volume 24,991
Today’s High 2,519.25
Today’s Low 2,490.15
52 Week High 3,008.94
52 Week Low 2,279.05
Shares Outstanding (mil) 172.56
Market Capitalization (mil) 466,533.00
Forward P/E 35.23
Dividend (Yield %) 21.00 ( 0.78 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, INR)
FY18
106,393
FY17
85,468
FY16
63,815
FY15
63,036
EPS (INR)
FY18
284.781
FY17
72.149
FY16
52.128
FY15
332.017
*Note: Units in Millions of Rupee
**Note: Units in Rupee

KEY RATIOS

Price to Earnings (TTM)
vs sector
35.23
32.76
Price to Sales (TTM)
vs sector
5.17
5.73
Price to Book (MRQ)
vs sector
--
5.47
Price to Cash Flow (TTM)
vs sector
26.64
23.29
Total Debt to Equity (MRQ)
vs sector
--
16.84
LT Debt to Equity (MRQ)
vs sector
--
12.51
Return on Investment (TTM)
vs sector
--
14.61
Return on Equity (TTM)
vs sector
--
16.34

EXECUTIVE LEADERSHIP

Ajay Piramal
Executive Chairman of the Board, Since
Salary: Rs79,860,000.00
Bonus: Rs31,944,000.00
Swati Piramal
Vice Chairman of the Board, Since 2013
Salary: Rs36,602,500.00
Bonus: Rs14,641,000.00
Peter DeYoung
Chief Executive Officer - Critical Care, Since
Salary: --
Bonus: --
Jonathan Sandler
Chief Executive Officer - Decision Resources Group, Since
Salary: --
Bonus: --
Vivek Sharma
Chief Executive Officer - Pharma Solutions, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

10th floor, Piramal Tower
Ganpatrao Kadam Marg
Lower Parel
MUMBAI     400070

Phone: +9122.38023083

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through three segments: Healthcare, Financial Services and Information Management. Its Healthcare segment includes pharma solutions, critical care, consumer products and imaging. Its Financial Services segment includes wholesale lending, alternative asset management and investments in Shriram Group. Its Information Management segment is engaged in Decision Resources Group (DRG). DRG's product and services portfolio consists of data and analytics, research products and global consulting services. The Company offers its products under brands, including Saridon, Lacto Calamine, i-pill/i-know, Polycrol, Tetmosol, Untox, Stop AllerG and Throatsil.

SPONSORED STORIES